Recombinant human MFG-E8 ameliorates colon damage in DSS-and TNBS-induced colitis in mice

Laboratory Investigation

Volumn 95, Issue 5, 2015, Pages 480-490

  Zhang, Yinzhong ^a   Brenner, Max ^a,b   Yang, Weng Lang ^a,b   Wang, Ping ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b TheraSource LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LACTADHERIN; RECOMBINANT HUMAN MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR FACTOR 8; RECOMBINANT PROTEIN; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; MEMBRANE ANTIGEN; MFGE8 PROTEIN, HUMAN; MILK PROTEIN; PROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE RESPONSE; DESCENDING COLON; DIARRHEA; DISEASE SEVERITY; DOSE RESPONSE; HISTOLOGY; LOOSE FECES; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM HEMORRHAGE; THERAPY EFFECT; WEIGHT REDUCTION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CELL LINE; CHEMICALLY INDUCED; COLON; DISEASE MODEL; DRUG EFFECTS; HUMAN; INFLAMMATORY BOWEL DISEASE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS; CELL LINE; COLITIS; COLON; CYTOKINES; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MILK PROTEINS; PROTECTIVE AGENTS; RECOMBINANT PROTEINS; TRINITROBENZENESULFONIC ACID;

EID: 84929071728     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2015.32     Document Type: Article

References (36)

1. Molodecky NA, Soon IS, Rabi DM et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142:46-54.
2. Sonnenberg A. Disability from inflammatory bowel disease among employees in West Germany. Gut 1989;30:367-370.
3. CDC. Inflammatory Bowel Disease (IBD) Atlanta: Centers for Disease Control and Prevention; 2012 (updated 15 July 2011; cited 23 October 2013). Available from http://www.cdc.gov/ibd/.
4. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology 2009;136:1182-1197.
5. Lichtenstein GR. Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response. Therap Adv Gastroenterol 2013;6:269-293.
6. Peyrin-Biroulet L, Lemann M. Review article: remission rates achievable by current therapies for inflammatory bowel disease. Aliment Pharmacol Ther 2011;33:870-879.
7. Aziz MM, Ishihara S, Mishima Y et al. MFG-E8 attenuates intestinal inflammation in murine experimental colitis by modulating osteopontin-dependent alphavbeta3 integrin signaling. J Immunol 2009;182:7222-7232.
8. Bu HF, Zuo XL, Wang X et al. Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest 2007;117:3673-3683.
9. Hagiwara C, Tanaka M, Kudo H. Increase in colorectal epithelial apoptotic cells in patients with ulcerative colitis ultimately requiring surgery. J Gastroenterol Hepatol 2002;17:758-764.
10. Di Sabatino A, Ciccocioppo R, Luinetti O et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum 2003;46:1498-1507.
11. Su L, Nalle SC, Shen L et al. TNFR2 activates MLCK-dependent tight junction dysregulation to cause apoptosis-mediated barrier loss and experimental colitis. Gastroenterology 2013;145:407-415.
12. Aziz M, Jacob A, Matsuda A et al. Pre-treatment of recombinant mouse MFG-E8 downregulates LPS-induced TNF-alpha production in macrophages via STAT3-mediated SOCS3 activation. PLoS ONE 2011;6: e27685.
13. Aziz M, Matsuda A, Yang WL et al. Milk fat globule-epidermal growth factor-factor 8 attenuates neutrophil infiltration in acute lung injury via modulation of CXCR2. J Immunol 2012;189:393-402.
14. Zhao QJ, Yu YB, Zuo XL et al. Milk fat globule-epidermal growth factor 8 is decreased in intestinal epithelium of ulcerative colitis patients and thereby causes increased apoptosis and impaired wound healing. Mol Med 2012;18:497-506.
15. Chogle A, Bu HF, Wang X et al. Milk fat globule-EGF factor 8 is a critical protein for healing of dextran sodium sulfate-induced acute colitis in mice. Mol Med 2011;17:502-507.
16. Qiang X, Li J, Wu R et al. Expression and characterization of recombinant human milk fat globule-EGF factor VIII. Int J Mol Med 2011;28:1071-1076.
17. Wirtz S, Neufert C, Weigmann B et al. Chemically induced mouse models of intestinal inflammation. Nat Protoc 2007;2:541-546.
18. Scheiffele F, Fuss IJ. Induction of TNBS colitis in mice. Curr Protoc Immunol 2002;Chapter 15: Unit 15.9.
19. Alex P, Zachos NC, Nguyen T et al. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis. Inflamm Bowel Dis 2009;15:341-352.
20. Coburn LA, Gong X, Singh K et al. L-arginine supplementation improves responses to injury and inflammation in dextran sulfate sodium colitis. PLoS ONE 2012;7:e33546.
21. Lee T, Lee E, Irwin R et al. beta-Arrestin-1 deficiency protects mice from experimental colitis. Am J Pathol 2013;182:1114-1123.
22. Day YJ, Marshall MA, Huang L et al. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction. Am J Physiol Gastrointest Liver Physiol 2004;286:G285-G293.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-408.
24. Yan Y, Kolachala V, Dalmasso G et al. Temporal and spatial analysis of clinical and molecular parameters in dextran sodium sulfate induced colitis. PLoS ONE 2009;4:e6073.
25. Dirisina R, Katzman RB, Goretsky T et al. p53 and PUMA independently regulate apoptosis of intestinal epithelial cells in patients and mice with colitis. Gastroenterology 2011;141:1036-1045.
26. Araki Y, Bamba T, Mukaisho K et al. Dextran sulfate sodium administered orally is depolymerized in the stomach and induces cell cycle arrest plus apoptosis in the colon in early mouse colitis. Oncol Rep 2012;28:1597-1605.
27. Otani A, Ishihara S, Aziz MM et al. Intrarectal administration of milk fat globule epidermal growth factor-8 protein ameliorates murine experimental colitis. Int J Mol Med 2012;29:349-356.
28. Hanayama R, Tanaka M, Miyasaka K et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004;304:1147-1150.
29. Brissette MJ, Lepage S, Lamonde AS et al. MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming. PLoS ONE 2012;7:e36368.
30. Miksa M, Amin D, Wu R et al. Maturation-induced down-regulation of MFG-E8 impairs apoptotic cell clearance and enhances endotoxin response. Int J Mol Med 2008;22:743-748.
31. Shah KG, Wu R, Jacob A et al. Recombinant human milk fat globule-EGF factor 8 produces dose-dependent benefits in sepsis. Intens Care Med 2012;38:128-136.
32. Cheyuo C, Jacob A, Wu R et al. Recombinant human MFG-E8 attenuates cerebral ischemic injury: its role in anti-inflammation and anti-apoptosis. Neuropharmacology 2012;62:890-900.
33. Ajakaiye MA, Jacob A, Wu R et al. Recombinant human MFG-E8 attenuates intestinal injury and mortality in severe whole body irradiation in rats. PLoS ONE 2012;7:e46540.
34. Matsuda A, Jacob A, Wu R et al. Milk fat globule-EGF factor VIII ameliorates liver injury after hepatic ischemia-reperfusion. J Surg Res 2013;180:e37-e46.
35. Zhang F, Shah KG, Qi L et al. Milk fat globule epidermal growth factorfactor 8 mitigates inflammation and tissue injury after hemorrhagic shock in experimental animals. J Trauma Acute Care Surg 2012;72: 861-869.
36. Valatas V, Vakas M, Kolios G. The value of experimental models of colitis in predicting efficacy of biological therapies for inflammatory bowel diseases. Am J Physiol Gastrointest Liver Physiol 2013;305: G763-G785.